Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.6 USD | -0.10% |
|
+46.07% | +337.57% |
06-14 | Wells Fargo Raises Price Target on Avidity Biosciences to $75 From $50, Maintains Overweight Rating | MT |
06-14 | Avidity Biosciences Prices $400.9 Million Offering of Shares | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AVIDITY BIOSCIENCES, INC. | Biopharmaceuticals | -0.10% | +46.07% | +337.57% | +226.73% | - | 4.2B | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- RNA Stock
- Charts Avidity Biosciences, Inc.
- Comparison Chart